Fig. 3From: The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)Schematic representation of the benefit cohorts and the assumed impact of treatment. *The number of uniquely treated individuals in any one country was assumed to be the maximum number of individuals treated in any single MDA for each countryBack to article page